DK3116891T3 - Immunglobulinrensning ved hjælp af forrensningstrin - Google Patents

Immunglobulinrensning ved hjælp af forrensningstrin Download PDF

Info

Publication number
DK3116891T3
DK3116891T3 DK15708522.6T DK15708522T DK3116891T3 DK 3116891 T3 DK3116891 T3 DK 3116891T3 DK 15708522 T DK15708522 T DK 15708522T DK 3116891 T3 DK3116891 T3 DK 3116891T3
Authority
DK
Denmark
Prior art keywords
purification
immunoglobulin
steps
purification steps
immunoglobulin purification
Prior art date
Application number
DK15708522.6T
Other languages
English (en)
Inventor
Melinda Gáspár
Ferenc Felföldi
Zsuzsa Benkö
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU1400131A external-priority patent/HUP1400131A1/hu
Priority claimed from HU1500053A external-priority patent/HUP1500053A1/hu
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of DK3116891T3 publication Critical patent/DK3116891T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/26Cation exchangers for chromatographic processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20Anion exchangers for chromatographic processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/165Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/22Affinity chromatography or related techniques based upon selective absorption processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241Tumor Necrosis Factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK15708522.6T 2014-03-10 2015-03-09 Immunglobulinrensning ved hjælp af forrensningstrin DK3116891T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU1400131A HUP1400131A1 (hu) 2014-03-10 2014-03-10 Immunoglobulin tisztítása elõtisztítási lépések alkalmazásával
HU1500053A HUP1500053A1 (hu) 2015-02-09 2015-02-09 Immunglobulin tisztítása elõtisztítási lépések alkalmazásával
PCT/EP2015/054862 WO2015135884A1 (en) 2014-03-10 2015-03-09 Immunoglobulin purification using pre-cleaning steps

Publications (1)

Publication Number Publication Date
DK3116891T3 true DK3116891T3 (da) 2020-05-04

Family

ID=89991731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15708522.6T DK3116891T3 (da) 2014-03-10 2015-03-09 Immunglobulinrensning ved hjælp af forrensningstrin

Country Status (15)

Country Link
US (1) US10487138B2 (da)
EP (2) EP3674310A1 (da)
JP (1) JP6293907B2 (da)
KR (1) KR101921552B1 (da)
CN (1) CN106103465B (da)
CA (1) CA2930350C (da)
DK (1) DK3116891T3 (da)
ES (1) ES2784749T3 (da)
HR (1) HRP20200711T1 (da)
HU (1) HUE048782T2 (da)
LT (1) LT3116891T (da)
PL (1) PL3116891T3 (da)
PT (1) PT3116891T (da)
SI (1) SI3116891T1 (da)
WO (1) WO2015135884A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3116891T3 (pl) 2014-03-10 2020-07-27 Richter Gedeon Nyrt. Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania
GB2539420B (en) * 2015-06-16 2021-01-13 Cytiva Sweden Ab Determination of chromatography conditions
JP6851109B2 (ja) * 2016-06-16 2021-03-31 Jsr株式会社 抗体を精製する方法及び担体を洗浄する方法
CN109563124A (zh) * 2016-06-17 2019-04-02 豪夫迈·罗氏有限公司 多特异性抗体的纯化
US20190211055A1 (en) * 2016-09-14 2019-07-11 Kinbio Ltd. Methods of purifying and qualifying antibodies
KR20190131082A (ko) * 2017-03-24 2019-11-25 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 재조합 항체 단편을 정제하는 방법
MA49962A (fr) * 2017-08-22 2020-07-01 Biogen Ma Inc Procédés de purification d'anticorps présentant des agrégats réduits à poids moléculaire élevé
KR20190047376A (ko) 2017-10-27 2019-05-08 주식회사 녹십자 개선된 면역글로불린의 정제방법
WO2019173731A1 (en) * 2018-03-08 2019-09-12 Bio-Rad Laboratories, Inc. Anionic exchange-hydrophobic mixed mode chromatography resin
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
GB201805142D0 (en) * 2018-03-29 2018-05-16 Ge Healthcare Bioprocess R&D Ab Separation method
WO2020016417A1 (en) * 2018-07-19 2020-01-23 Ichnos Sciences S.A. Liquid antibody formulation
KR102209790B1 (ko) * 2018-12-20 2021-02-01 에이치케이이노엔 주식회사 친화성 크로마토그래피를 이용한 백신용 바이러스 정제방법
CN113227789A (zh) * 2018-12-30 2021-08-06 豪夫迈·罗氏有限公司 基于pH梯度SPR的结合测定
US20220184526A1 (en) * 2019-03-21 2022-06-16 Agency For Science, Technology And Research A Method of Capturing and/or Purifying a Target
HU231498B1 (hu) * 2019-04-04 2024-05-28 Richter Gedeon Nyrt Immunglobulinok affinitás kromatográfiájának fejlesztése kötést megelőző flokkulálás alkalmazásával
CN114025843A (zh) * 2019-06-10 2022-02-08 武田药品工业株式会社 抗体纯化方法及其组合物
JP2022546901A (ja) 2019-09-05 2022-11-10 バイオ-ラッド・ラボラトリーズ・インコーポレーテッド アニオン交換-疎水性混合モードクロマトグラフィー樹脂
AU2021355325A1 (en) * 2020-04-10 2022-11-03 Plasma Technologies, Llc Compositions and methods for simplified high efficiency isolation of proteins
CN113563469A (zh) * 2020-04-28 2021-10-29 江苏中新医药有限公司 高回收率纯化阿达木单抗的方法
AU2021265591A1 (en) * 2020-05-01 2022-12-22 Kashiv Biosciences, Llc An improved process of purification of protein
AU2022359021A1 (en) * 2021-10-08 2024-05-02 Kashiv Biosciences, Llc Separation of pre-peak in fusion protein sample by using size exclusion high performance liquid chromatography
AU2022361768A1 (en) * 2021-10-08 2024-05-02 Kashiv Biosciences, Llc Separation of pre-peak and post-peak in fusion protein sample by using size exclusion high performance liquid chromatography
CN114133446A (zh) * 2021-12-31 2022-03-04 方坦思(上海)生物医药有限公司 单克隆抗体的纯化方法
CN115304673B (zh) * 2022-06-24 2024-10-01 上海赛伦生物技术股份有限公司 一种马抗破伤风特异性免疫球蛋白F(ab’)2的纯化方法及其应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368904A1 (en) * 1987-07-16 1990-05-23 Schering Corporation Purification of gm-csf
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
US4983722A (en) 1988-06-08 1991-01-08 Miles Inc. Removal of protein A from antibody preparations
WO1991018975A1 (en) * 1990-05-31 1991-12-12 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method for purifying hiv reverse transcriptase
ES2156859T5 (es) 1991-03-18 2008-03-16 New York University Anticuerpos monoclonales y quimericos especificos para el factor de necrosis tumoral humano.
WO1992022653A1 (en) 1991-06-14 1992-12-23 Genentech, Inc. Method for making humanized antibodies
DE69329503T2 (de) 1992-11-13 2001-05-03 Idec Pharma Corp Therapeutische Verwendung von chimerischen und markierten Antikörpern, die gegen ein Differenzierung-Antigen gerichtet sind, dessen Expression auf menschliche B Lymphozyt beschränkt ist, für die Behandlung von B-Zell-Lymphoma
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
CN103275221B (zh) 1996-02-09 2016-08-17 艾伯维生物技术有限公司 结合人TNFα的人抗体
DK0973804T3 (da) 1997-04-07 2007-05-07 Genentech Inc Anti-VEGF-antistoffer
EP1222572A2 (en) 1999-08-26 2002-07-17 Symtec Limited Methods and devices for selecting data files
YU103003A (sh) 2001-06-26 2006-05-25 Abgenix Inc. Antitela za opgl
US20030040027A1 (en) * 2001-08-16 2003-02-27 Gerd Ritter Method for determining protein component in a biological sample
DE10155984A1 (de) 2001-11-15 2003-05-28 Boehringer Ingelheim Pharma Verfahren zur Reduktion des Liganden-leakage von Affinitätschromatographie-Matrices
ES2545067T3 (es) 2002-04-26 2015-09-08 Genentech, Inc. Purificación de proteínas basada en la no afinidad
PT1601697E (pt) 2003-02-28 2007-09-04 Lonza Biologics Plc Purificação de anticorpos através de proteína a e cromatografia de troca iónica.
EP1614693A4 (en) * 2003-03-31 2006-07-19 Kirin Brewery PURIFICATION OF A HUMAN MONOCLONAL ANTIBODY AND A HUMAN POLYCLONAL ANTIBODY
DK3095793T3 (da) 2003-07-28 2020-05-25 Genentech Inc Reducering af udvaskning af protein A under en protein A-affinitetskromatografi
ATE360647T1 (de) * 2003-11-05 2007-05-15 Ares Trading Sa Verfahren zur aufreinigung von il-18-bindendem protein
EP1718386A1 (en) 2004-02-27 2006-11-08 GE Healthcare Bio-Sciences AB A process for the purification of antibodies
US20080312425A1 (en) 2004-08-30 2008-12-18 Lonza Biologics Plc. Ion Exchange Chromatography and Purification of Antibodies
KR20140015166A (ko) 2007-10-30 2014-02-06 제넨테크, 인크. 양이온 교환 크로마토그래피에 의한 항체 정제
JP2011523408A (ja) 2008-05-15 2011-08-11 ノボ・ノルデイスク・エー/エス 抗体精製方法
AU2009347206C1 (en) 2008-10-20 2016-12-08 Abbvie Inc. Isolation and purification of antibodies using Protein A affinity chromatography
EP2360183B1 (en) * 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Antibody purification method by mixed mode chromatography utilizing an arginine-containing loading solution
SG178078A1 (en) * 2009-07-24 2012-03-29 Hoffmann La Roche Optimizing the production of antibodies
US8536316B2 (en) * 2009-08-07 2013-09-17 Emd Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
EP3736338A1 (en) * 2009-09-01 2020-11-11 F. Hoffmann-La Roche AG Enhanced protein purification through a modified protein a elution
WO2011049798A1 (en) 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Use of mixed mode chromatography for the capture and purification of basic antibody products
US20130116413A1 (en) 2009-12-29 2013-05-09 Dr. Reddy's Laboratories, Inc. Purification of proteins
HRP20171095T4 (hr) 2010-05-25 2022-07-22 F. Hoffmann - La Roche Ag Postupci pročišćavanja polipeptida
CA2813747A1 (en) * 2010-10-11 2012-04-19 Chen Wang Processes for purification of proteins
JP6261499B2 (ja) * 2011-07-11 2018-01-17 グレンマーク ファーマシューティカルズ, エセ.アー. Ox40と結合する抗体およびその使用
EP2773439A4 (en) 2011-10-31 2015-07-01 Merck Sharp & Dohme CHROMATOGRAPHY METHOD FOR DECOMPOSING HETEROGENEOUS ANTIBODY AGGREGATES
PL3257564T5 (pl) 2011-11-02 2024-10-07 F. Hoffmann-La Roche Ag Chromatografia elucyjna z przeładowaniem
WO2013180647A1 (en) * 2012-05-31 2013-12-05 Agency For Science, Technology And Research Chromatographic purification of immunoglobulin g preparations with particles having multimodal functionalities
PL3116891T3 (pl) 2014-03-10 2020-07-27 Richter Gedeon Nyrt. Oczyszczanie immunoglobuliny z zastosowaniem etapów wstępnego oczyszczania

Also Published As

Publication number Publication date
PL3116891T3 (pl) 2020-07-27
CA2930350C (en) 2021-04-06
WO2015135884A1 (en) 2015-09-17
JP6293907B2 (ja) 2018-03-14
CN106103465A (zh) 2016-11-09
US10487138B2 (en) 2019-11-26
HUE048782T2 (hu) 2020-08-28
HRP20200711T1 (hr) 2020-07-24
JP2017507907A (ja) 2017-03-23
EP3116891A1 (en) 2017-01-18
LT3116891T (lt) 2020-03-25
PT3116891T (pt) 2020-05-18
CN106103465B (zh) 2021-01-08
SI3116891T1 (sl) 2020-07-31
CA2930350A1 (en) 2015-09-17
ES2784749T3 (es) 2020-09-30
KR20160124107A (ko) 2016-10-26
EP3674310A1 (en) 2020-07-01
KR101921552B1 (ko) 2018-11-23
EP3116891B1 (en) 2020-02-12
US20170058019A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
DK3116891T3 (da) Immunglobulinrensning ved hjælp af forrensningstrin
NL301117I1 (nl) trastuzumab deruxtecan
DK3186376T3 (da) Fremgangsmåder til forbedring af cas9-medieret manipulationseffektivitet
DK3556775T3 (da) Anti-lag-3 antistoffer til behandling af hæmatologiske maligniteter
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3180331T3 (da) Polymorfer af selinexor
DK3110988T3 (da) Metoder til behandling af lithiumholdige materialer
DK3560954T3 (da) Modificeret j-kæde
DK3757214T3 (da) Sammensætninger til modulering af sod-1-ekspression
DK3131928T3 (da) Trifunktionelt antigenbindende molekyle
DK3122444T3 (da) Fremgangsmåde til fremstilling af membraner
DK3113858T3 (da) Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater
DK3303618T3 (da) Fremgangsmåder til prognose af prostatacancer
BR112016021624A2 (pt) indexação de locais baseada em polígono
DK3393468T3 (da) Fremgangsmåder til behandling af en immundefektsygdom
CL2016002165A1 (es) Compuestos de aminocarbonilcarbamato
DK3124651T3 (da) Indretning til fremstilling af organisk hydrid
DK3164716T3 (da) Fremgangsmåde til diagnosticering af neurodegenerative sygdomme
DK3597189T3 (da) Krystallinske forbindelser
DK3125942T3 (da) Forstøvning af immunoglobulin
DK3191466T3 (da) Azetidinyloxyphenylpyrrolidinforbindelser
DK3795591T3 (da) Cys80-konjugerede immunoglobuliner
ES1157711Y (es) Filtro
ITUB20155097A1 (it) Anticorpi umanizzati anti-BAG3
DE112015003855A5 (de) Regenwasserfilter